Skip to content
Search

Latest Stories

LOG Pharma expands manufacturing site with ‘multi-million-dollar’ modern clean room

LOG Pharma expands manufacturing site with ‘multi-million-dollar’ modern clean room

Equipped with advanced automated online inspection, LOG Pharma’s new facility is designed to meet the high standards of pharmaceutical companies. 

LOG Pharma Primary Packaging, a global leader in pharmaceutical packaging solutions, has unveiled a new, multi-million-dollar, state-of-the-art clean room at its manufacturing site in Kibbutz Ashdot Ya’acov Ichud, Israel.

The new facility, part of a broader 600-square meter expansion of the company’s manufacturing site, is designed to meet the high standards of pharmaceutical companies.


With this ISO 8-certified clean room and newly expanded facility, LOG Pharma aims to enhance productivity for global innovative and generic pharmaceutical companies by offering high-quality barrier packaging solutions, tailored to precise product specifications.

The facility is equipped with cutting-edge automated online inspection, ensuring immediate and reliable detection of any defects, thus enhancing the production of LOG’s innovative and sustainable packaging solutions.

Shaul Bassi, CEO of LOG Pharma, said: “The massive investment in the new clean room emphasizes our commitment to meet and exceed customer expectations and further strengthens LOG’s position as a leading primary packaging provider for the pharmaceutical industry.”

“We have witnessed a rapid increase in demand for our packaging solutions by pharmaceutical companies worldwide. This move will enable us to boost production capability and underpin our future growth.”

Untitled 3

LOG Pharma noted that its new clean room reinforces the company’s commitment to Good Manufacturing Practices (GMP) compliance for primary packaging quality assurance, full production control, and adherence to the highest manufacturing benchmarks in the industry.

The expansion reflects LOG’s strategic vision to enhance its production capabilities and maintain its competitive edge in the highly demanding pharmaceutical packaging market.

In addition to the Israel facility, the company also operates a manufacturing site in Hungary, strengthening its global footprint in the industry.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less